Thirty years’ experience providing a wide range of corporate advisory and investment banking services to senior management and boards of international pharmaceuticals and healthcare companies. Clients range from Fortune 500 corporations to private equity-backed start-ups on six continents. Provides an outside-in perspective, partnering with management to deliver well-defined and strongly grounded qualitative and financial analyses based on comprehensive, customized research. Delivers fact-based, scenario-driven conclusions to guide senior management and corporate boards on market opportunities, growth planning and capital allocation. Brings a single-minded focus to investment banking engagements, delivering maximum value to clients through expert transaction process management and negotiations.


  • Animal Health
  • APIs
  • Brand Pharmaceuticals
  • Consumer Health/OTC
  • Generic Pharmaceuticals
  • Medical Cannabis
  • PBMs
  • Pharmaceutical Marketing
  • Pharmaceutical Royalties
  • Specialty Pharmaceuticals